РЕАЛЬНАЯ ПРАКТИКА ПРИМЕНЕНИЯ КЛИНИЧЕСКИХ РЕКОМЕНДАЦИЙ ПО ПРОФИЛАКТИКЕ РИСКА ВЕНОЗНЫХ ТРОМБОЭМБОЛИЧЕСКИХ ОСЛОЖНЕНИЙ ВО ВРЕМЯ БЕРЕМЕННОСТИ, РОДОВ И ПОСЛЕРОДОВОМ ПЕРИОДЕ

Библиографические ссылки:

Lutsey P.L., Zakai N.A. Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol. 2022; Oct 18: 1-15.https://doi.org/10.1038/s415-022-00787-6.

Nichols K.M., Henkin S., Creager M.A. Venous thromboembolism associated with pregnancy: JACC focus seminar. J Am Coll Cardiol. 2020; 76(18): 2128-2141.https://doi.org/10.1016/j.jacc.2020.06.090;

Момот А.П. Николаева МГ, Сердюк Г.В. с соавт. Оценка состояния системы гемостаза при физиологически протекающей беременности. Алгоритмы обследования в группах риска. Тромбоз, гемостаз, реология. 2019; 4(80): 80-130.https://doi.org/10.25555/THR.2019.4.0903.

Alshaikh N.A. Protein S: a central regulator of blood coagulation. Clin Lab. 2022; 68(8).https://doi.org/10.7754/Clin.Lab.2021.211010..

Malm J., Laurell M., Dahlbäck B. Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception. Br J Haematol. 1988; 68(4): 437-443.https://doi.org/10.1111/j.1365-2141.1988.tb04232.x.

Soma-Pillay P., Nelson-Piercy C., Tolppanen H., Mebazaa A. Physiological Changes in pregnancy. Cardiovasc J Afr. 2016; 27(2): 89-94.https://doi.org/10.5830/CVJA-2016-021.

Bukhari S., Fatima S., Barakat A.F., et al. Venous thromboembolism during pregnancy and postpartum period. Eur J Intern Med. 2022; 97: 8-17.https://doi.org/10.1016/j.ejim.2021.12.013.

Edebiri O., Áinle F.N. Risk factors, diagnosis and management of venous thromboembolic disease in pregnancy. Breath (Sheff). 2022; 18(2): 220018.https://doi.org/10.1183/20734735.0018-2022.

Венозные осложнения во время беременности и послеродовом периоде. Акушерская тромбоэмболия. Клинические рекомендации. 2021.

Padda J., Khalid K., Mohan A., Pokhriyal S., Batra N., Hitawala G., et al. Factor V Leiden G1691A and prothrombin gene G2021A mutations on pregnancy outcome. Cureus. 2021; 13(8): e17185.https://doi.org/10.7759/cureus.17185..

Mitric D., Popusoi O., Catrinici R., Friptu V. The obstetric complications in women with hereditary thrombophilia. Med Pharm Rep. 2019; 92(2): 106-110.https://doi.org/10.15386/cjmed-1097..

Arachchilage D.J., Mackillop L., Chandratheva A., Motawani J., MacCallum P., Laffan M. Thrombophilia testing: a British society for haematology guideline. Br J Haematol. 2022; 198(3): 443-458.https://doi.org/10.1111/bjh.18239.

Николаева М.Г. Сердюк Г.В., Момот К.А., Ясафова Н.Н., Момот А.П., Елыкомов В.А. АПС-резистентность, связанная с мутацией фактор V Лейден (генотип GA): клиническая реализация при беременности. Тромбоз, гемостаз и реология. 2018; 73(1): 47-54.

Шмаков Р.Г., Пырегов А.В., Вавилова Т.В. Венозные осложнения во время беременности и послеродовом периоде. акушерская тромбоэмболия. Клинические рекомендации. Кодирование по Международной статистической классификации болезней и проблем, связанных со здоровьем О22/О87/О88. Возрастная группа: взрослые/дети. Москва, 2021.

Момот А.П., Николаева М.Г. Тромбофилии в акушерско-гинекологической практике. Гепаринопрофилактика. Медицинский совет 2017; 13: 71-78.https://doi.org/10.21518/2079-701X-2017-13-71-78.

Waters J.H. The role of viscoelastic testing in the management of parturient. Transfusion. 2020; 60 Suppl 6: S70-S74.https://doi.org/10:1111/trf.15928.

Cohen S.L., Feizullayeva C., McCandlish J.A., Sanelli P.C., McGinn T., Brenner B., et al. Comparison of international societal guidelines for the diagnosis of suspected pulmonary embolism during pregnancy. Lancet Haematol. 2020; 7(3): e247-e258.https://doi.org/10.1016/S2352-3026(19)30250-9.

Bai C., Wu H., Wu W., Feng P., Nie M., Zhao L., Meng F. Anticoagulation for mechanical heart valves during pregnancy: a case report and literature review. Medicine (Baltomore). 2022; 101(52): e32550.https://doi.org/10.1097/MD.0000000000032550

Middleton P., Shepherd E., Gomersall J.C. Venous thromboembolism prophylaxis for women at risk during pregnancy and at the early postnatal period. Cochrane Database. 2021; 3(3): CD001689.https://doi.org/10.1002/14651858.CD001689.

Chau C., Campagna J., Vial M., Rambeaud C., Loundou A., Bretelle F. Use of a personalized iterative score to evaluate risk of venous thromboembolism during pregnancy and pierperium. Int J Gynaecol Obstet. 2019; 144(3): 277-282.https://doi.org/10.1002/ijgo.12754.

Wiegers H.M., Middeldorp S. Contemporary best practice in the management of pulmonary embolism during pregnancy. Ther Adv Respir Dis. 2020; 14: 1753466620914222.https://doi.org/10.1177/1753466620914222.

Wan T., Skeith L., Karovitch A., Rodger M., Le Gal G. Guidance for the diagnosis of pulmonary embolism during pregnancy: consensus and controversies. Thromb Res. 2017; 157: 23-28.https://doi.org/10.1016/j.thromres.2017.06.025..

Robert-Ebadi H., Moumneh T., Le Gal G., Righini M. Diagnosis of pulmonary embolism during pregnancy. Diagnostics (Basel). 2022; 12(8): 1875.https://doi.org/10.3390/diagnostics12081875.

American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy. Obstet Gynecol. 2018; 132(1): e1-e17.https://doi.org/10.1097/AOG.0000000000002706.

Bates S.M., Rajasekhar A., Middeldorp S., McLintock C., Rodger M.A., James A.H., et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018; 2(22): 3317-3359.https://doi.org/10.1182/bloodadvances.2018024802.

Boban A., Paulus S., Lambert C., Hermans C. The value and impact of anti-Xa activity monitoring for prophylactic dose adjustment of low-molecular-weight heparin diring pregnancy: a retrospective study. Blood Coagul Fibrinolysis. 2017; 28(3): 199-204.https://doi.org/10.1097/MBC.0000000000000573.

Aggarwal S.R., Economy K.E., Valente A.M. State of art management of mechanical heart valves during pregnancy. Curr Treat Options Cardiovasc Med. 2018; 20(12): 102.https://doi.org/10.1007/s11936-018-0702-3.

Keepanasseril A., Pilai A.A., Baghel J., Pande S.N., Mondal N., Munuswamy H., et al. Alternatives to low molecular weight heparin for anticoagulation in pregnant women with mechanical heart valves in middle-income countries: a cohort study. Glob Heart. 2021; 16(1): 68.https://doi.org/10.5334/gh.1011.

Lameijer H., Aalberts J.J., van Veldhuisen D.J., Meijer K., Pieper P.G. Efficacy and safety of direct oral anticoagulants during pregnancy: a systemic literature review. Thromb Res. 2018; 169: 123-127.https://doi.org/10.1016/thromres.2018.07.022..

Muysson M., Marshall K., Datta P., Rewers-Felkins K., Baker T., Hale T.W. Rivaroxaban treatment in two breastfeeding mothers: a case series. Breastfeed Med. 2020; 15(1): 41-43.https://doi.org/10.1089/bfm.2019.0124.

Андреева М.Д., Карахалис Л.Ю., Пенжоян Г.А., Шаповалова О.А., Высоцкий О.В., Пенжоян М.А. Родоразрешение в условиях инфицирования COVID-19: клиническое наблюдение. Акушерство и гинекология: новости, мнения, обучение. 2020; 8(2): 25-35.https://doi.org/10.24411/2303-9698-2020-12001.

Lee M-S., Chen W., Zhang Z., Duan L., Ng A., Spencer H.T., et al. J Am Heart Assoc. 2016; 5(4): e003182.https://doi.org/10.1161/JAHA.115.003182..

Georgiopolous G., Tsiachris D., Kordalis A., Kontogiannis C., Spartalis M., Pietri P., et al. Pharmacotherapeutic strategy for atrial fibrillation in pregnancy. Expert Opin Pharmacother. 2019; 20(13): 1625-1636.https://doi.org/10.1080/14656566.2019.1621290.

Lang I.M., What is new in the 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy? Wien Klin Wochenschr. 2020; 132(3-4): 69-72.https://doi.org/10.1007/s00508-019-1529-y.

Стрюк Р.И., Бунин Ю.А., Гурьева В.М., Иртюга О.Б., Коков Л.С., Коломацкая О.Е. и др. Диагностика и лечение сердечно-сосудистых заболеваний при беременности. 2018. Национальные рекомендации. Российский кардиологический журнал. 2018; 3(155): 91-134.https://doi.org/10.15829/1560-4071-2018-3-91-134.